Sign inJoin waitlistJoin the waitlist

RL

Raphael Lizcano

Assistant Professor of Medicine · Geisel School of Medicine

Credentials: · · · · ·

History

Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital Fellowship
Present
Geisel School of Medicine
Present

Hematology
2016–2017
Internal Medicine
Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
2013–2016
Geisel School of Medicine at Dartmouth
2009–2013

Research

Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study
Clinical Lymphoma · 2025 · 5 citations
Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline Exposure
Case report · JACC Case Reports · 2025
The Clinical Utility of Real-Time Patient-Reported Outcomes in Cell Therapy Recipients
Transplantation and Cellular Therapy · 2025

Christi Hayes
2 papers
JH
John Hill
2 papers
Kenneth Meehan
2 papers
AC
Amy Chan
1 paper
Arvind Suresh
1 paper · 1 as a resident
EO
Elizabeth O'Donnell
1 paper
GM
Grant Moncrief
1 paper
Iris Jaffe
1 paper
Jenica Upshaw
1 paper
NC
Nicholas Camarda
1 paper
Parth Shah
1 paper
RT
Richard Travers
1 paper

Clinical trials

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029